[Towards a personalized pretransplantation conditioning in patients with myelodysplastic syndromes]

Med Sci (Paris). 2018 Jan;34(1):9-11. doi: 10.1051/medsci/20183401002. Epub 2018 Jan 31.

[Article in French]

Authors

Marie Goulard¹, Christine Dosquet², Christine Chomienne²

Affiliations

¹ Inserm UMR-S-1131, 1, avenue Claude Vellefaux, 75010 Paris, France.
² Inserm UMR-S-1131, 1, avenue Claude Vellefaux, 75010 Paris, France - APHP, Hôpital Saint-Louis, unité de biologie cellulaire, 1, avenue Claude Vellefaux, 75010 Paris, France.

PMID: 29384085
DOI: 10.1051/medsci/20183401002

No abstract available

Publication types

News

MeSH terms

Adolescent
Adult
Child
Child, Preschool
Hematopoietic Stem Cell Transplantation*
Humans
Infant
Mutation
Myelodysplastic Syndromes / genetics
Myelodysplastic Syndromes / therapy*
Precision Medicine / methods
Transplantation Conditioning / methods*
Tumor Suppressor Protein p53 / genetics
Young Adult

Substances

Tumor Suppressor Protein p53